Introduction
The main obstacle in successful cancer treatments is the resistance of tumor cells to conventional therapy (radiation and antineoplastic drugs). Among factors of tumor resistance, an important role is attributed to the heat shock protein Hsp72. Normal tissues usually express a constitutive member of the Hsp70 family, Hsc73, but not Hsp72, which is upregulated in stressful conditions. In contrast, tumors often express constitutively both Hsc73 and Hsp72 (Jaattela, 1999; Jolly and Morimoto, 2000) . Furthermore, there are a number of reports indicating that high expression of Hsp72 in human tumors, especially of epithelial origin, correlates with high invasiveness, metastasis, poor prognosis of the disease and resistance to chemotherapy (Ciocca et al., 1993; Costa et al., 1997; Vargasroig et al., 1997; Nanbu et al., 1998) . For example, in colorectal and lung cancers, expression of Hsp72 closely correlates with advanced clinical stages and positive lymph node involvement (Volm et al., 2002; Hwang et al., 2003) . These findings suggest that Hsp72 provides a selective advantage to tumor cells during cancer progression.
The antiapoptotic effect of Hsp72 overexpression is well established in both normal and transformed cell lines in vitro, and one of the important mechanisms of promotion of cell survival by Hsp72 apparently involves suppression of the proapoptotic JNK pathway (Gabai et al., 1997; Mosser et al., 1997) . The antiapoptotic activity of Hsp72 may play an important role in tumor development. For example, rapidly growing cells in solid tumors may suffer from hypoxia, as well as nutrient and growth factor deprivation due to insufficient vascularization. Under these conditions, suppression of apoptosis may become critical for tumor development. In addition, tumor cells should develop mechanisms to avoid killing by FAS or TNF and other factors of the immune system. To cope with these dangerous factors, tumor cells develop special mechanisms of antiapoptotic protection, for example, activation of survival pathways (ERK, NF-kB, Akt), or suppression of proapoptotic pathways (mutations/deletions of p53, bax, Apaf, etc.) (Igney and Krammer, 2002) . Hsp72 may serve as a potent antiapoptotic factor, thus promoting cancer development. In fact, it was demonstrated that overproduction of Hsp72 in fibrosarcoma cells significantly enhanced their tumorigenic potential in athymic mice (Jaattela, 1995) , while transgenic mice that expressed human Hsp72 at high levels developed multiple lymphomas (Seo et al., 1996) . Moreover, expression of Hsp72 in Rat-1 fibroblasts led to formation of foci, anchorage-independent growth, and development of tumors in nude mice (Volloch and Sherman, 1999) . In promoting cancer, Hsp72 may play a critical role in maintaining viability and proliferation of cancer cells. Indeed, it was demonstrated that depletion of Hsp72 by adenovirus-encoded Hsp72 antisense RNA causes rapid death of various types of tumor cells, while nontransformed cells are quite resistant to such treatment (Nylandsted et al., 2000) . Treatment with adenovirus expressing Hsp72 antisense RNA was effective with human glioblastoma, breast and colon carcinoma grown as xenografts in nude mice (Nylandsted et al., 2002) .
In other studies, however, no significant cell death was seen as a direct result of Hsp72 depletion, but rather sensitization of cells to various anticancer factors and drugs. For example, in ME-180 cervical and c2BBE colonic carcinomas, antisense RNA-mediated Hsp72 downregulation increased their sensitivity to TNF (Jaattela et al., 1998; Musch et al., 2001) ; at the same time, no sensitization to doxorubicin was seen in colonic carcinoma, while significant effect was observed in cervic carcinoma (Jaattela et al., 1998; Musch et al., 2001) . However, when Hsp72 was downregulated by RNA interference in U1810 non-small-cell lung carcinoma cells, no sensitization to apoptosis induced by irradiation, cis-platinum and etoposide was observed (Ekedahl et al., 2003) . Of note, apoptosis does not represent the main mode of demise of carcinomas after radiation and anticancer drug treatments at clinically relevant doses. Under these conditions, cells usually die via mitotic catastrophe or undergo permanent growth arrest (senescence), with both responses manifested in vitro as loss of the colony-forming ability of cells (Roninson et al., 2001; Roninson, 2003) . At present, there are almost no data regarding the effects of Hsp72 on these cell responses. Understanding the role of Hsp72 in tumor cells is important since Hsp72 may potentially be used as a new target for anticancer therapeutics.
In this work, we used several approaches to suppress Hsp72 expression in human prostate carcinoma cells and to study whether Hsp72 downregulation affects their survival and sensitivity to anticancer treatments.
Results

Generation of prostate carcinoma cells with reduced levels of Hsp72
We investigated the role of constitutive expression of Hsp72 in human prostate carcinoma cells in viability, growth and resistance to anticancer treatments. Previously, it was demonstrated that specific downregulation of Hsp72 by expression of the full-length Hsp72 antisense RNA using an adenovirus vector rapidly killed various tumor cell lines, including prostate tumor cells PC-3 and DU-145, while being nontoxic to normal prostate epithelial cells (Nylandsted et al., 2002) . Similarly, we observed that treatment of PC-3 and DU-145 with adenovirus expressing Hsp72 antisense RNA indeed caused severe toxicity within 48 h (not shown). This effect, however, may not entirely be due to the downregulation of Hsp72, since a control adenovirus (expressing GFP) also caused toxicity, especially during prolonged incubation (data not shown). In order to dissociate the effects of downregulation of Hsp72 from toxic effects of adenovirus, we switched to retroviral vectors expressing siRNA or full-length Hsp72 antisense RNA. In the preliminary experiments, we found that retroviral infection on its own, that is, with control retroviral vector, is not toxic to either PC-3 or DU-145 cells (not shown). Therefore, in our further study we used retroviral vectors.
To downregulate Hsp72 specifically, we employed two constructs that target two distinct regions of the hsp72 gene (see Materials and methods). DU-145 and PC-3 cells were infected with high titers of retroviruses encoding these siRNAs, and the levels of Hsp72 were monitored at various time points. In these populations of PC-3 and DU-145 cells, the levels of Hsp72 dropped by almost 70% within 72 h (Figure 1 ). This downregulation was very specific, since no significant changes in expression of the constitutive homologue Hsc73 were seen ( Figure 1 ). In contrast to previous reports, there was no significant cell death under these conditions. The viability was assessed by MTT assay (Figure 1 ) and by the cleavage of PARP, a substrate of caspase-3 ( Figures  2, 3 ). Since the lack of the cell killing in our experiments Figure 1 Specific depletion of Hsp72 in prostate adenocarcinoma lines by siRNA expressed using a retrovirus vector. DU-145 and PC-3 cells were infected with retroviral vectors expressing siRNAs to Hsp72 (si1 and si2) or empty vector (RQ) as described in Materials and methods. At 48 h after infection, puromycin (0.5 mg/ ml) was added to select infected cells, and, after another 48 h, expression of Hsp72 (a, upper and lower panels) and Hsc73/Hsp72 (middle panel) was assessed by immunoblotting with SPA810 and SPA820 antibodies, respectively. Addition of puromycin (pur) drastically reduced the viability of wild-type DU-145 cells within 48 h as measured by MTT assay, but did not cause significant toxicity either in siHsp72-or vector (RQ)-infected cells (b)
Hsp72 and chemoresistance of human prostate carcinoma VL Gabai et al could potentially be due to incomplete infection of the cell population, we compared the survival of cells infected with retroviruses encoding Hsp72 siRNA and control retrovirus upon selection of cells with stably integrated viruses. The presence of the puromycin resistance gene in the retroviruses allows rapid puromycin selection within 48 h. While almost no uninfected cells survived the selection, there was about 80% survival rate with cells infected with the control retrovirus, and a similar fraction survived with the Hsp72 siRNA virus (Figure 1 ), manifesting high efficiency of infection. Therefore, since cells infected with Hsp72 siRNA virus survived, while the level of Hsp72 dropped significantly, these data indicate that downregulation of Hsp72 in prostate carcinoma cells does not affect the cells' viability, and that previously reported cell killing was attributed to a combination of Hsp72 depletion and a toxicity of adenoviruses. We also did not observe any considerable changes in morphology or growth rate of PC-3 and DU-145 cells infected with these retroviruses.
Hsp72 downregulation enhances apoptosis of prostate carcinoma cells treated with anticancer agents
As mentioned in the Introduction, expression of Hsp72 at high levels can confer protection against apoptosis (see, for example, Mosser et al., 1997; Gabai et al., 1998) . Therefore, after establishment of PC-3 and DU-145 cells with reduced Hsp72 levels, we investigated whether Hsp72 plays a role in resistance to stresses and anticancer treatments. Most likely, Hsp72 may affect cancer cells' sensitivity to hyperthermia, which is being used in clinics along with radiation and chemotherapy. Indeed, exposure of DU-145/siHsp72 or PC-3/siHsp72 to 451C for 20 min led to apoptosis of about 50% of cells, while in parental cells heat shock at these conditions caused little apoptosis (Figures 2,3 ). Of note, if in control cells mild heat treatment led to a marked Hsp72 build-up, accumulation of Hsp72 in cells expressing Hsp72 siRNA was strongly reduced (Figures 2,3) . Interestingly, as mentioned above, siRNA-treated cells and control cells had similar levels of Hsc73 (Figure 1) . Therefore, despite high levels of Hsc73, constitutive levels of Hsp72 appear to play an important role in thermoresistance of prostate carcinoma cells.
Among novel anticancer drugs which have been tested in clinical trials for treatment of prostate and other cancers are proteasome inhibitors (Adams, 2004) , and inhibitors of a distinct heat shock protein, Hsp90 (Neckers, 2002) . These drugs strongly induce Hsp72, which may potentially enhance resistance to these drugs. Therefore, we hypothesized that downregulation of To further address the role of Hsp72 in resistance of prostate cancer cells, we investigated whether downregulation of Hsp72 is able to sensitize them to agents that do not cause protein damage and do not induce heat shock proteins, such as TNF. Indeed, our experiments indicated that treatment of DU-145 or PC-3 cells with TNF for 48 h did not cause any Hsp72 accumulation (not shown). Interestingly, apoptosis in DU-145/ siHsp72 and PC-3/siHsp72 cells was higher than in the corresponding control cells (Figures 2, 3 ). These data indicate that endogenous expression of Hsp72 in prostate carcinoma makes cells less sensitive to a wide range of antitumor agents.
Long-term depletion of Hsp72 by antisense RNA
Expression of the Hsp72 siRNA in prostate tumor cells provides an efficient but temporal downregulation of Hsp72. In fact, in spite of selection of a population with integrated retroviruses, by the fourth week after infection, the levels of Hsp72, as well as cells' resistance to heat shock and drugs, were restored (not shown). We established lines with constitutively reduced levels of Hsp72 by using a retroviral vector expressing full-length Hsp72 RNA in the antisense orientation. Of note, the antisense RNA approach was used in previous studies that reported cancer cell killing by depletion of Hsp72 with adenoviral vectors (Nylandsted et al., 2000 (Nylandsted et al., , 2002 . As with the Hsp72 siRNA-expressing retroviruses, we did not observe cell killing after infection with the retrovirus expressing the Hsp72 antisense RNA. After infection and selection with hygromycin, we generated several clones of PC-3 cells (PC-3/AS), which expressed lower levels of Hsp72. Two of these clones with reduction of Hsp72 by more than 70% (AS6 and AS7) were chosen for further study. Importantly, expression of Hsp72 antisense RNA in these cells did not affect levels of expression of Hsc73, as well as other chaperones Hsp90 and Hsp27 (Figure 4 ). These clones, when grown in the presence of hygromycin, showed stably reduced levels of Hsp72 for more than 6 months in culture. Interestingly, upon prolonged culturing of the PC-3/AS6 and PC-3/AS7 clones, cells developed additional properties that were not seen in short-term experiments with Hsp72/siRNA cells. In fact, in about 3 weeks after depletion of Hsp72, significant changes in cell morphology and growth rate were seen, that is, PC-3/AS6 and PC-3/AS7 cells grew about 1.5 times slower than parental cells (not shown), they had flattened morphology and formed less dense colonies on plates (Figure 4b , and see also Figure 6c ), although their colony-forming ability was essentially the same as with parental cells (Figure 6c) . Importantly, long-term depletion of Hsp72 with antisense RNA in PC-3 cells significantly reduced some aspects of cells tumorigenic capacity. In fact, when plated in soft agar, PC-3/AS6 cells formed about five times fewer colonies than the parental cells (Figure 4c ).
Similarly to PC-3 siRNA cells, PC-3/AS6 and PC-3/ AS7 cells were more sensitive to heat shock, proteasome inhibitor MG-132, Hsp90 inhibitor radicicol and TNF ( Figure 5 , data for PC-3/AS7 cells not shown). With prolonged cultivation for more than 3 weeks, sensitivity to these treatments gradually increased (not shown).
As mentioned in the Introduction, apoptosis does not represent the main mode of carcinoma cell killing by the clinically relevant doses of hyperthermia, radiation or Figure 4 Effect of retrovirus expressing antisense RNA to Hsp72 on expression of chaperones, cell morphology and anchorageindependent growth of PC-3 cells. PC-3 cells were infected with retrovirus expressing antisense RNA to Hsp72 and 48 h later hygromycin (0.4 mg/ml) was added to select resistant clones. After 2 weeks of selection, single clones were isolated and checked by immunoblotting for expression of various Hsps (a). (b) Morphology of parental (WT) and PC-3/AS6 cells with reduced Hsp72 levels (phase contrast, Â 10). (c) Colony formation in soft agar. Parental PC-3 and PC-3/AS6 cells were plated in soft agar as described in Materials and methods, and 3 weeks later colonies were counted Hsp72 and chemoresistance of human prostate carcinoma VL Gabai et al drugs, since these treatments rather cause mitotic catastrophe or permanent growth arrest with features of cell senescence (Roninson et al., 2001; Roninson, 2003) . Therefore, we assessed how Hsp72 downregulation affects the overall survival of PC-3 cells by assessing their colony-forming ability. Indeed, while only about 50% of PC-3/AS cells underwent apoptosis after treatment with heat shock or MG-132 ( Figure 5 ), there was a dramatic loss of the colony-forming ability of cells following these treatments, while the parental cells were much more resistant to these treatments (Figure 6a, b) . Furthermore, the colony-forming ability of PC-3/AS6 cells after treatments with oxidative stress (H 2 O 2 ), gamma radiation, cis-platinum, or microtubule-affecting drugs (viblastine or taxol) was also significantly reduced compared to control PC-3 cells (Table 1 ). The enhanced drug sensitivity of PC-3/AS6 cells was not universal, since no significant difference in survival was seen with doxorubicin treatment, and PC-3/AS6 cells were even more resistant to etoposide than parental cells (Table 1) .
We studied in more detail the mechanism of death of PC-3 and PC-3/AS6 cells after gamma irradiation (6 Gy), and found that there was no or little apoptosis (either assayed by PARP cleavage or Hoechst staining for nuclear fragmentation) during the first 48 h after the treatment. Afterwards, there was a steady accumulation of detached dead cells in normal PC-3 culture, which also did not demonstrate PARP cleavage. In PC-3/AS6 culture, there were substantially more floating dead cells at the same doses of irradiation. In addition, surviving cells in PC-3/AS6 but not in normal PC-3 culture became enlarged, flattened and highly vacuolated, resembling senescent cells. These cells were not dividing and a significant fraction of them were stained positively Wild-type PC-3 or PC-3/AS6 cells were exposed to heat shock at 451C (a), or inhibitor of proteasome MG-132 (b), or g irradiation (c) and plated to assess formation of colonies 10 days later, as described in Materials and methods. Note that PC-3/AS6 cells without treatment form larger colonies due to a larger cell size, but after irradiation there are fewer colonies formed by PC-3/AS6, and these colonies are much smaller than in control due to a poor cell division (c) (Figure 6c ). Similar modes of death/senescence were observed after treatment with 10 mg/ml of cis-platinum (data not shown). Therefore, besides suppressing apoptosis (e.g., in case of heating, MG-132, or radicicol), Hsp72 apparently plays a role in maintaining the overall survival of cells exposed to diverse agents, such as DNA-damaging agents (e.g., g irradiation, cis-platinum), or microtubule-damaging drugs (taxol or vinblastin).
Prolonged Hsp72 downregulation affects MAP kinase and NF-kB signaling pathways
In a variety of cells, activation of JNK and p38 kinases was shown to stimulate apoptosis, while stimulation of ERK and Akt pathways enhances cell survival. Previous studies from our and other labs demonstrated that overexpression of Hsp72 suppresses stress-induced activation of JNK, p38, ASK1 and ERK kinases (Gabai et al., 1997; Song et al., 2001; Park et al., 2002; Yaglom et al., 2003) . To further investigate the role of the constitutively expressed Hsp72 in prostate tumor cells, we compared heat-induced activation of JNK, p38, ERK and Akt pathways in PC-3 cells with downregulated Hsp72 (either with RNA interference, or antisense RNA). Depletion of Hsp72 did not cause significant changes in endogenous or heat-induced activities of p38, ERK or Akt pathways in the shortterm experiments with PC-3/siHsp72 or PC-3/AS cells (not shown). On the other hand, in these experiments, we observed slower rate of JNK inactivation during recovery after heat shock ( Figure 7 ). We have previously observed similar more prolonged JNK activity following heat shock treatment upon inhibition of Hsp72 induction in human fibroblast (Gabai et al., 2000) . As with fibroblasts, this extended JNK activity in PC-3/siHsp72 cells is probably due to a stronger inhibition of JNK phosphatases following heat treatment (Meriin et al., 1999) . Since increased thermosensitivity of fibroblasts upon blocking of Hsp72 expression was dependent on the duration of JNK activity (Gabai et al., 2000) , we suggest that a similar mechanism of thermosensitization may operate in PC-3/siHsp72 cells. Upon development of high sensitivity to anticancer drugs in the long-term experiments with PC-3/AS cells, dramatic changes in several signaling pathways took place. In fact, we observed strong reduction of the basal activity of ERK survival pathway, as well as suppression of the heat shock activation of this pathway (Figure 8) . Furthermore, activation of ERK by MG-132 and a mitogenic phorbol ester (PDB) was also suppressed (Figure 8 ), indicating that there was a general inhibition of this pathway in PC-3/AS cells, which may significantly contribute to the increased cell's sensitivity to anticancer treatments. JNK activation by heat shock was also mildly suppressed in these cells, while the p38 kinase activity was not affected (Figure 8 ).
To further explore this phenomenon, we assessed whether Hsp72 downregulation in PC-3/AS cells affects the activities of the upstream components of ERK pathway, MEK1/2 and Raf-1. It was previously Figure 7 Effect of short-term Hsp72 downregulation on heatinduced JNK activation. PC-3 vector-infected (RQ) and siRNA Hsp72-infected cells were exposed to heat shock at 451C for 20 min and JNK activation was measured at different intervals after recovery from heat shock by immunoblotting with antibody against phospho-JNK. Antitubulin immunoblotting was used as a protein-loading control Figure 8 Effect of long-term Hsp72 downregulation on activities of MAP kinase pathways. PC-3 parental and PC-3/AS6 cells were exposed to heat shock at 451C for 10-15 min (a-c), or to 2 mM of MG-132 (d), 1 mM of phorbol dibutirate PDB (e), or 10 ng/ml of TNF (f) and activities of ERK1/2 (a, d, e, f), JNK (b) and p38 (c) were assessed by immunoblotting with antibodies to phosphorylated (active) forms of these kinases (see Materials and methods). Total expression of ERK1/2 was measured with the corresponding antibody (a, lower panel)
Hsp72 and chemoresistance of human prostate carcinoma VL Gabai et al demonstrated that treatment of cells with geldanamycin, an inhibitor of another chaperone, Hsp90, leads to ERK1/2 inactivation (dephosphorylation) due to the rapid degradation of an upstream regulator of the pathway, Raf-1 (Hostein et al., 2001) . Since Hsp72 cooperates with Hsp90 in protein refolding, it could be involved in maintaining stability of Raf-1, and, therefore, we expected that Hsp72 downregulation may decrease the levels of Raf-1, thus inhibiting ERK cascade. However, the levels of Raf-1 increased rather than decreased in PC-3/AS cells (Figure 9 ), indicating that Hsp72 downregulation did not reduce Raf-1 stability. At the same time, both endogenous and heatinduced activation (phosphorylation of Ser217/221) of MEK1/2, a substrate of Raf-1, were significantly suppressed in PC-3/AS6 cells (Figure 9 ), indicating downregulation of Raf-1 activity. The phosphorylation status of certain serines plays a critical role in Raf-1 activity: that is, Ser-259 is dephosphorylated while Ser-338 is phosphorylated upon mitogenic stimulation (see, for example, . Heat shock treatment did not increase Ser-338 phosphorylation in PC-3 cells (not shown); however, it caused marked dephosphorylation of Ser-259. This dephosphorylation was strongly suppressed after Hsp72 depletion in PC-3/AS cells (Figure 9 ). Therefore, Hsp72 appears to play a critical role in maintaining the activity of ERK signaling pathway at the level of Raf-1.
Since in many cell types ERK1/2 activation is involved in cell survival, including survival of heat shock, we suggested that downregulation of ERK cascade in PC-3/AS cells may significantly contribute to increased heat sensitivity of these cells. Indeed, inhibition of ERK1/2 activity with U0126 in parental PC-3 cells makes them almost as thermosensitive as PC-3/AS6 cells, as judged by PARP cleavage (data not shown). Therefore, it seems that, although in PC-3/AS cells there was no upregulation of proapoptotic JNK and p38 pathways, prominent downregulation of the ERK survival pathway may be responsible for their increased sensitivity to heat shock, and, possibly, to other treatments.
In addition to the ERK pathway, the NF-kB pathway also plays a major role in cell survival (Karin and Lin, 2002) , and there are several reports of its constitutive activation in prostate tumor cells including PC-3 cells (Gasparian et al., 2002; Suh et al., 2002; Suh and Rabson, 2004) . Furthermore, as demonstrated previously, increased activity of NF-kB pathway in hormone-independent prostate tumor cell lines such as PC-3 is associated with increased activity of I-kB kinase IKKb, causing faster phosphorylation and degradation of I-kB (Gasparian et al., 2002; Suh et al., 2002; Suh and Rabson, 2004) . Therefore, we compared the rate of I-kB phosphorylation at Ser-32 (which is phosphorylated by IKK) and its degradation in parental PC-3 and PC-3/ AS6 cells in response to TNF, a potent activator of this pathway. As seen in Figure 10 , TNF induced rapid phosphorylation and degradation of I-kB in parental PC-3 but not in PC-3/AS6 cells, indicating a severe impairment of this pathway. To compare the endogenous activities of I-kB kinase (in the absence of TNF), PC-3 and PC-3/AS cells were treated with a proteasome inhibitor MG-132 to prevent degradation of the phosphorylated form of I-kB. Whereas in parental PC-3 cells there was a strong time-dependent increase in IkB phosphorylation, a little increase in I-kB phosphorylation was observed in PC-3/AS6 cells (Figure 10 ). To test whether Hsp72 downregulation affects NF-kBdependent gene expression, we assessed endogenous NF-kB activity using NF-kB-luciferase reporter system. PC-3/AS cells, demonstrated only about 25% of endogenous levels of expression of NF-kB-driven luciferase compared to parental cells (data not shown), indicating that, in fact, endogenous and TNF-induced activities of the NF-kB pathway become impaired in PC-3 cells after prolonged depletion of Hsp72. Figure 9 Effect of long-term Hsp72 downregulation on heatinduced Raf-1 and MEK activation. Parental PC-3 and PC-3/AS6 cells were heat shocked at 451C for 20 min, and then transferred to 371C for indicated times. Activation (dephosphorylation of Ser-259) was measured by immunoblotting with antibody specific to pSer-259 of Raf-1 (a). Expression of Raf-1 was measured by immunoblotting with antibody against total Raf-1 (b). Activation (phosphorylation of MEK1/2) was measured with phospho-specific antibody against Ser217/221 of MEK (c) Figure 10 Prolonged Hsp72 downregulation affects NF-kB signaling pathway. Parental PC-3 and PC-3/AS6 cells were treated with 10 ng/ml of TNF (a, b), or 5mM of MG-132 (c) and phosphorylation and degradation of I-kB were assessed by immunoblotting with the corresponding antibodies Hsp72 and chemoresistance of human prostate carcinoma VL Gabai et al
It is well known that activation of the NF-kB pathway in response to TNF leads to expression of prosurvival genes (e.g., inhibitors of caspases IAPs) and protects various cells from TNF-induced apoptosis (for reviews, see, for example, Wang et al., 1998; Karin and Lin, 2002) . It was also demonstrated that activation of NF-kB by TNF could inhibit proapoptotic signaling by JNK (Papa et al., 2004) . However, TNF-induced activation of JNK was lower rather than higher in PC-3/AS6 cells (not shown). At the same time, TNFinduced ERK activity, which plays an antiapoptotic role (Tran et al., 2001) , was strongly inhibited in PC-3/AS6 cells (see Figure 8f) . Taken together, these results indicate that, although Hsp72 downregulation mildly inhibited proapoptotic JNK activation induced by TNF, suppression of two survival pathways, NF-kB and ERK, apparently overrides this effect, leading to increased sensitivity to TNF observed in these cells (see Figure 5d ).
Discussion
As mentioned in the Introduction, the majority of previous studies investigated the detrimental effects of Hsp72 depletion on viability of tumor cells using adenovirus encoding Hsp72 antisense RNA. However, adenoviral infection of prostate tumor cells by itself caused subtle toxicity, and therefore cell killing by Hsp72 antisense RNA delivered on adenovirus can manifest a combination of toxicity of adenoviruses and of Hsp72 downregulation. To avoid these complications, we delivered Hsp72 siRNA and antisense RNA on retroviral vectors, which allows efficient and rapid generation of cell lines with reduced levels of Hsp72. According to our experience, these vectors, in contrast to adenoviral vectors, are not toxic to a wide variety of normal and transformed cell lines, and have no effects on cell growth and sensitivity to stresses (Gabai et al., unpublished data) .
We observed that permanent and specific downregulation of Hsp72 in PC-3 and DU-145 prostate adenocarcinoma with retroviruses expressing full-length antisense RNA and siRNA to Hsp72 did not cause compensatory upregulation of other molecular chaperones (Figures 1, 4) . In contrast to previous observations with adenoviral-mediated downregulation of Hsp72 with antisense RNA, we did not observe loss of viability of prostate carcinoma cells upon Hsp72 downregulation either with antisense or siRNA retroviral vectors. Since adenoviral vectors in our study caused subtle toxicity to tumor but not normal cells by themselves, we believe that observed toxicity of adenoviral-mediated Hsp72 downregulation was due to the sensitizing effects of Hsp72 depletion to adenovirus toxicity or vice versa. Furthermore, generation of stable tumor cell lines of different origins with very low levels of Hsp72 in several labs, including ours, also argue that Hsp72 is generally not necessary for maintaining the viability of tumor cells. However, our recent findings indicate that certain tumor cell lines do require Hsp72 to avoid activation of a default senescence program (in preparation).
We found, however, that prolonged (more than 3-4 weeks) Hsp72 suppression caused changes in cells' morphology, growth rate and ability to form colonies in soft agar (Figures 4, 6) . The ability to form colonies in semisolid medium (i.e., anchorage independence) is the hallmark of transformed cells, and decrease in anchorage independence after prolonged Hsp72 downregulation is consistent with previous findings that overexpression of Hsp72 in Rat-1 fibroblasts leads to transformation of these cells manifested in the capability of forming colonies in soft agar and tumors in nude mice (Volloch and Sherman, 1999) . Interestingly, we have found that at higher densities of PC-3/AS6 cells their colony formation ability in soft agar was partially restored (Gabai et al., unpublished data) , suggesting that upon depletion of Hsp72 cells may have higher requirement for some secreted factors that are needed for anchorage-independent growth.
We found that both short-term and long-term Hsp72 downregulation markedly increased prostate carcinoma sensitivity to some anticancer treatments (hyperthermia, inhibitors of proteasome and Hsp90), which are currently either in use in clinic or in clinical trials. For instance, proteasome inhibitor PS-341 (velcade) has been recently approved for clinical use and shows a very high potency in treatments of multiple myelomas; now it is in clinical trials for various other forms of tumors, including prostate cancer (Adams et al., 1999; Adams, 2002) . The sensitization to inhibitors of proteasome and Hsp90 is probably because Hsp72 along with Hsp90 and proteasome is involved in handling of abnormal proteins by a cell, and inhibition of these pathways simultaneously appears to have a devastating consequence for cancer cells. Our findings therefore suggest that developing an inhibitor of Hsp72 and using it in combination with these modalities could be a novel interesting approach towards cancer treatment.
Besides proteotoxic stresses, Hsp72 downregulation also made prostate carcinoma cells sensitive to TNF (Figures 2, 3, 5) , a natural antitumor defense agent, indicating that Hsp72 overexpression in tumor cells may confer resistance to some hostile factors of tumor microenvironment (i.e., host immunological system).
Another important new finding in this study is the observation that Hsp72 is apparently capable of suppressing not only apoptosis but also mitotic catastrophe and permanent growth arrest (senescence) caused by radiation and low concentrations of anticancer drugs ( Figure 6 , Table 1 ). Indeed, PC-3 cells with reduced levels of Hsp72 demonstrated higher rates of nonapoptotic cell death (presumably, mitotic catastrophe) and senescence after radiation and cis-platinum, resulting in a marked loss of colony-forming ability. This finding is consistent with the recent observation that fibroblasts derived from mice lacking Hsp72 (Hsp70.1/Hsp70.3 knockout mice) had enhanced radiation sensitivity (loss of colony-forming ability) than wild-type mice (Hunt et al., 2004) . Therefore, our data indicate that Hsp72 is involved in enhancing survival of tumor cells not only by inhibiting apoptosis, as it was demonstrated previously, but also by blocking other forms of cell demise.
In the apoptotic pathway, overexpression of Hsp72 was demonstrated to suppress efflux of cytochrome c from mitochondria and caspase activation apparently via inhibition of upstream components of apoptotic cascade, ASK1, JNK and p38 (Gabai et al., 2002; Park et al., 2002) . So, we expected that Hsp72 downregulation would have an opposite effect, that is, it would increase the activities of JNK and p38. Indeed, in prostate tumor cells with Hsp72 knockdown by siRNA, we found more prolonged activation of JNK after heat shock (Figure 7) , which is in accordance with our earlier observation with fibroblasts (Gabai et al., 2000) . Surprisingly, however, if levels of Hsp72 were reduced for longer time, it did not enhance the activity of JNK but rather mildly suppressed it (Figure 8 ). By contrast, long-term Hsp72 downregulation led to suppression of major cellular survival pathways ERK and NF-kB (Figures 8, 10 ), which can explain the increased sensitivity of cells to stresses and anticancer drugs. Indeed, as demonstrated in numerous studies, these pathways are involved in protection of cells from various stresses, suppressing apoptosis and increasing their clonogenic ability (Wang et al., 1996 (Wang et al., , 1998 (Wang et al., , 1999 Yamagishi et al., 1997; Franklin and McCubrey, 2000; Gabai et al., 2000; Tran et al., 2001; Orlowski et al., 2002; Kucharczak et al., 2003) . Downregulation of these pathways may not only sensitize prostate tumor cells to stresses and drugs, but also may be responsible for slow growth and reduced anchorage-independent growth (for a review, see Hanahan and Weinberg, 2000) .
Materials and methods
Recombinant retroviral and adenoviral vectors
For knockout of Hsp72 expression, we used RNAi-Ready pSIREN-RetroQ vector purchased from BD Biosciences. The vector is provided prelinearized for ligation with doublestranded oligonucleotide encoding a hairpin siRNA; it also contains a puromycin resistance gene for selection of stable transfectants. Two sequences of human Hsp72 gene were selected as targets for RNAi:
Si #1 (start 474): CAG GTG ATC AAC GAC GGA GAC Si #2 (start 1961): GAA GGA CGA GTT TGA GCA CAA For production of retroviruses, we used 293T cells which were co-transfected using GenePorter (GTS) or Lipofectamine 2000 (Invitrogene) with plasmids expressing retroviral proteins GagPol, G (VSVG pseudotype), or EGFP (kindly provided by Dr Jeng-Shin Lee, Harvard Medical School) or our constructs. At 48 h after transfection, supernatants containing the retrovirus were collected and frozen at À701C. Cells were infected with two-times diluted supernatant and 10 mg/ml polybrene overnight, washed, and selection with puromycin (0.5 mg/ml) was started 48 h after infection. Retroviral vector expressing EGFP was used as a control for infection efficiency: usually 70-90% of cells were fluorescent 2-3 days after infection.
For generation of recombinant retroviruses expressing fulllength Hsp72 antisense RNA, we used pRevTRE vector (Clontech) containing hygromycin resistance gene. Retrovirus was produced in PT67 packaging cell line (Clontech). PC-3 cells were infected with supernatant from PT67 cells in the presence of 10 mg/ml polybrene, and selection with 0.4 mg/ml of hydromycin was started 72 h after infection.
Adenoviruses expressing antisense RNA to Hsp72 or GFP were kindly provided by Dr D Mosser (Guelf University, Canada), and are described elsewhere (Gabai et al., 2000) . Adenoviruses were propagated in 293T cells and concentrated by cesium chloride density centrifugation.
Cell cultures and treatments
DU-145 and PC-3 cells were purchased from ATCC and cultivated in RPMI-1640 with 10% FBS. For treatment with heat shock, irradiation or drugs, cells were plated at 35 mm at 50-70% confluency. Cells were heated in a water bath at 45.070.11C. Irradiations of cells were performed using 137 Cs source (Gamma Cell 40, Canada) at 64 rad/min. Doxorubicin (Biomol) was dissolved in PBS; etoposide, cis-platinum (Sigma), MG-132, radicicol, taxol, vinblastine and U0126 (all from Biomol) were dissolved in DMSO and the solvent (not more than 0.1%) was used as a control.
Viability and soft agar assays
To measure the cell viability with MTT (Sigma), it was added to cells to a final concentration of 0.5 mg/ml for 2 h. Formed formazan crystals were dissolved in acidic 2-propanol, and optical density was measured at 570 nm.
To measure apoptosis, cells were collected and lysed in buffer containing 4 M urea, 10% (v/v) of glycerol, 2% SDS, 5% (v/v) of 2-mercaptoethanol and 0.01% of bromophenol blue. Samples were heated at 951C for 3 min and then passed through a 27 G1/2 syringe to decrease viscosity. After PAGE and immunoblotting with anti-PARP antibody (Pharmigen), blots were developed with ECL reagent (Amersham), films were scanned, and cleavage of PARP was quantified using Quantity One software (Biorad).
To measure clonogenic survival, after treatment with heat shock, irradiation or drugs, cells were counted and plated on 100 mm Petri dishes. After 10 days, the formed colonies were stained with 0.5% crystal violet in 70% ethanol and quantified using Quantity One software (Biorad).
To analyse anchorage-independent growth, 5 Â 10 4 cells were seeded in 35-mm plates with 2 ml 0.3% (w/v) low-melting agarose, which was overlaid onto 2 ml of 0.6% (w/v) agarose. Both layers contained RPMI-1640 with 10% FBS. At 3 weeks after plating, macroscopic colonies were counted.
Immunoblotting, kinase assays and NF-kB assay Expression of Hsp72, Hsc73, Hsp90 and Hsp27 was assessed using immunoblotting with corresponding antibodies from Stressgene. For kinase assay, cells were washed twice with PBS, aspirated and lysed in 150 ml of lysis buffer per 35 mm dish (40 mM HEPES, pH 7.5; 50 mM KCl; 1% Triton X-100; 2 mM DTT, 1 mM Na 3 VO 4 ; 50 mM b-glycerophosphate; 50 mM NaF; 5 mM EDTA; 5 mM EGTA; 1 mM PMSF; 1 mM benzamedine; 5 mg/ml of each: leupeptine, pepstatine A, aprotinin). Lysates were clarified by centrifugation in a microcentrifuge at 15 000 r.p.m. for 5 min. Total protein concentration was measured in supernatants by Biorad Protein Assay, after which they were diluted with lysis buffer to achieve equal protein concentration in all samples. All procedures were performed at 41C. ERK1/2, p38 and JNK activities were assayed by immunoblotting of cell lysates with anti-phospho-ERK1/2 antibody, anti-phospho-p38 antibody (both from Cell Signaling) and anti-phospho-JNK antibody (Promega).
Expression of c-Raf was assessed with an antibody from BD transduction Lab, and phosphorylation of Ser-259 of c-Raf was assessed with an antibody from Cell Signaling.
Phosphorylation of Ser-32 of I-kB was assessed with an antibody from Cell Signaling, and degradation of IkBa-with C21 antibody from Santa Cruz.
To measure endogenous NF-kB activity, we used NF-kBluciferase reporter system (Promega), and CMV promoterdriven luciferase as a control for efficiency of transfection and translation. Cells were transfected with these vectors using GenePorter and 48 h after transfection luciferase activity was measured using the luciferase cell culture lysis reagent (Promega) by luminometer.
Abbreviations ERK, extracellular signal-regulated kinase; Hsp, heat shock protein; JNK, c-Jun N-terminal kinase; MAP, mitogenactivated kinase; MTT, 3-[4, 5-dimethylthiasol-2-yl]-2,5-diphenyltetrasolium bromide; NF-kB, nuclear factor kappa B; PARP, poly(ADP-ribose) polymerase; PDB, phorbol dibutirate; SiRNA, small interfering RNA; TNF, tumor necrosis factor.
